Nasitop (Bilastine)

Bilastine, the active ingredient in Nasitop, is an antihistamine presented as an oral tablet for oral use. It selectively antagonizes peripheral H1 receptors, preventing histamine‑mediated allergic symptoms such as sneezing, itching, and hives, and is indicated for use in adults and adolescents with allergic rhinitis or chronic idiopathic urticaria.

GNH USA supplies Nasitop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for global markets.

Bilastine is used to manage allergic conditions by targeting histamine‑mediated pathways. - Allergic rhinitis: reduces nasal congestion, sneezing, and itching associated with seasonal or perennial allergies. - Chronic idiopathic urticaria: alleviates wheals and pruritus in patients with persistent hives. - Hay fever: provides symptom relief for seasonal pollen‑induced allergic reactions.

Bilastine may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Dry mouth: sensation of oral dryness. - Fatigue: feeling of tiredness without loss of alertness. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmia: rare cases of irregular heart rhythm.

When considering Nasitop, several safety measures should be observed. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Elderly: monitor for increased sensitivity to central nervous system effects. - Avoid concomitant sedatives or alcohol: may enhance drowsiness. - Store at ambient temperature: keep in the original pack, protect from moisture.

Bilastine can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Ketoconazole: strong CYP3A4 inhibitor that can raise bilastine plasma levels. - Erythromycin: macrolide antibiotic that may increase bilastine exposure. - Ritonavir: protease inhibitor that can significantly elevate bilastine concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may experience additive blood pressure effects. - Theophylline: possible alteration of metabolism requiring observation. - Alcohol: can potentiate sedation in susceptible individuals.